Johnson & Johnson Innovation - JJDC
UnclaimedAt a Glance
- Check Size
- $3M – $75M
- Stage
- Series A, Series B+
- Sectors
- Digital Health, Biotech, AI
- Founded
- 1973
- HQ
- New Brunswick, NJ
About Johnson & Johnson Innovation - JJDC
Johnson & Johnson Innovation - JJDC is a venture capital firm based in Menlo Park, CA founded in 1973. Healthcare innovation wherever it originates. The firm focuses on Series A, Series B+ investments across sectors including Digital Health, Biotech, AI. The firm manages $3B in assets under management. Notable portfolio companies include Verb Surgical, Veracyte, Auris Health, Legend Biotech, Actelion, Synthes, Momenta and SpringWorks. Investing in revolutionary healthcare companies that have the potential to profoundly change the trajectory of health for humanity.
Investment Thesis
“Investing in revolutionary healthcare companies that have the potential to profoundly change the trajectory of health for humanity.”
Leadership Team
Chris Picariello has led JJDC as president since 2019. He arrived from inside Johnson & Johnson, where he served as chief business officer and chief financial officer for the Innovative Medicine research and development unit, a background that keeps the venture arm tethered to the therapeutic priorities of the operating company rather than running as a standalone financial investor. Debi Watson serves as vice president of venture investments and is the unit's most public voice on strategy and on the discipline that has carried it through five decades of shifting healthcare cycles. The team sits within Johnson & Johnson Innovation, which pairs JJDC's equity investing with the JLABS incubator network and regional innovation centers, giving portfolio management teams access to Johnson & Johnson scientists, clinical expertise and commercial infrastructure alongside the capital itself.
Firm Type
Sector Focus
Investment Stage
Notable Portfolio Companies
Fund History
- JJDC raises no outside limited partner capital and has no numbered funds.
- Incorporated in 1973 as the venture investment arm of Johnson & Johnson, it invests directly off the parent company's balance sheet, which makes its capital evergreen and its holding periods open-ended.
- Johnson & Johnson had been taking minority positions in outside entrepreneurs since the 1960s; the 1973 incorporation formalized the practice and gave JJDC an unbroken record that reached the half-century mark in 2023, making it one of the oldest continuously operating corporate venture units anywhere.
- Deployment runs across pharmaceuticals, medical devices, consumer health and medtech, typically at Series A and later, and is coordinated with the wider Johnson & Johnson Innovation organization.
- Because commitments come from the corporate treasury rather than a fixed vintage, annual pace tracks Johnson & Johnson's own research, development and licensing priorities rather than a fund's investment period, and the unit carries no pressure to return capital on a ten-year clock.
Frequently Asked Questions
What stage does Johnson & Johnson Innovation - JJDC invest at?
Johnson & Johnson Innovation - JJDC primarily invests at the Series A, Series B+ stages. This means they focus on companies that are scaling their go-to-market after proving product-market fit.
Where is Johnson & Johnson Innovation - JJDC located?
Johnson & Johnson Innovation - JJDC is headquartered in New Brunswick, NJ. Many of their portfolio companies are also based in this region, though they invest across geographies.
What sectors does Johnson & Johnson Innovation - JJDC focus on?
Johnson & Johnson Innovation - JJDC focuses on investments in Digital Health, Biotech, AI. Their portfolio reflects deep expertise and networks within these sectors.
What is Johnson & Johnson Innovation - JJDC's typical check size?
Johnson & Johnson Innovation - JJDC's typical investment check size ranges from $3M to $75M. Actual amounts may vary based on the stage, sector, and specific opportunity.
Similar Firms
Fund Operations Resources
Running a fund like Johnson & Johnson Innovation - JJDC? Independent guides to the software and processes emerging managers use to operate.
Best Fund Administration Software
Independent breakdown of fund administration platforms by fund size.
LP Reporting Software
Tools for capital account statements and investor updates.
Portfolio Monitoring Tools
How GPs track company performance across the portfolio.
VC CRM Software
Deal-flow and relationship management for investors.
Related tools and reading
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.